| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-P3506 |
Retatrutide |
Agonist |
99.96% |
Unkown |
| HY-P3375 |
Mazdutide |
Agonist |
99.97% |
Unkown |
| HY-P0054 |
GLP-1(7-36), amide acetate |
|
99.01% |
Unkown |
| HY-P4146 |
Survodutide |
Agonist |
99.99% |
Unkown |
| HY-121835 |
GLP-1R agonist 2 |
Agonist |
99.57% |
Unkown |
| HY-P0054A |
GLP-1(7-36), amide |
Agonist |
99.90% |
Unkown |
| HY-P1141 |
GLP-1(9-36)amide |
Antagonist |
99.69% |
Unkown |
| HY-101116 |
GLP-1R Antagonist 1 |
Antagonist |
99.67% |
Unkown |
| HY-P11274A |
Zenagamtide sodium |
Agonist |
99.96% |
Unkown |
| HY-P3506A |
Retatrutide TFA |
Agonist |
99.47% |
Unkown |
| HY-103546 |
BETP |
Agonist |
99.48% |
Unkown |
| HY-P1024 |
GLP-2(1-33)(human) |
Agonist |
98.43% |
Unkown |
| HY-P0054B |
GLP-1(7-36), amide TFA |
|
98.82% |
Unkown |
| HY-P10736A |
AMG133 peptide payload TFA |
Agonist |
99.70% |
Unkown |
| HY-P1023 |
VIP(6-28)(human, rat, porcine, bovine) |
Antagonist |
98.09% |
Unkown |
| HY-P1160 |
Bay 55-9837 |
Agonist |
99.56% |
Unkown |
| HY-P3366 |
Ecnoglutide |
Agonist |
99.93% |
Unkown |
| HY-124622 |
NNC-0640 |
Modulator |
98.43% |
Unkown |
| HY-P10736 |
AMG133 peptide payload |
|
99.94% |
Unkown |
| HY-129658A |
TT-OAD2 |
Agonist |
99.59% |
Unkown |
| HY-P3291 |
Dapiglutide |
Agonist |
98.52% |
Unkown |
| HY-P2231 |
Cotadutide |
Agonist |
99.80% |
Unkown |
| HY-142162 |
LSN3318839 |
Modulator |
99.22% |
Unkown |
| HY-10930 |
UNC0321 |
Inhibitor |
99.91% |
Unkown |
| HY-P2625 |
GLP-2(3-33) |
Agonist |
99.82% |
Unkown |
| HY-P0150 |
Glucagon (19-29), human |
Inhibitor |
99.11% |
Unkown |
| HY-P0014S1 |
Liraglutide-13C5,15N tetraTFA |
Agonist |
97.74% |
Unkown |
| HY-P1144 |
Oxyntomodulin (bovine, porcine) |
Agonist |
99.77% |
Unkown |
| HY-P3101 |
GLP-1(28-36)amide |
|
99.18% |
Unkown |
| HY-P1145A |
Glucagon-like peptide 1 (1-37), human TFA |
Agonist |
99.55% |
Unkown |
| HY-P1348 |
GLP-1 moiety from Dulaglutide |
|
99.60% |
Unkown |
| HY-116819 |
VU0453379 |
Modulator |
98.0% |
Unkown |
| HY-145632 |
Pemvidutide |
Agonist |
99.40% |
Unkown |
| HY-N0630 |
Shanzhiside methyl ester |
Agonist |
99.97% |
Unkown |
| HY-103547 |
L-168049 |
Antagonist |
99.94% |
Unkown |
| HY-P1143A |
[Des-His1,Glu9]-Glucagon amide TFA |
Antagonist |
98.36% |
Unkown |
| HY-P1141A |
GLP-1(9-36)amide TFA |
Antagonist |
98.61% |
Unkown |
| HY-112679 |
GLP-1 receptor agonist 2 |
Agonist |
98.70% |
Unkown |
| HY-P10032 |
NN1177 |
Agonist |
99.54% |
Unkown |
| HY-P3102 |
GLP-1(32-36)amide |
|
98.44% |
Unkown |
| HY-50675 |
GRA Ex-25 |
Inhibitor |
99.07% |
Unkown |
| HY-141840 |
GLP-1R modulator C5 |
Modulator |
99.81% |
Unkown |
| HY-50159 |
Glucagon receptor antagonist-3 |
Antagonist |
99.78% |
Unkown |
| HY-P11237 |
Enicepatide |
Agonist |
98.16% |
Unkown |
| HY-P10019 |
Pegsebrenatide |
Agonist |
95.50% |
Unkown |
| HY-P5815 |
GLP-1 (1-36) amide (human, rat) |
|
98.10% |
Unkown |
| HY-P10031 |
SAR441255 |
Agonist |
99.84% |
Unkown |
| HY-50158 |
Glucagon receptor antagonist-2 |
Antagonist |
99.23% |
Unkown |
| HY-P3617 |
Glucagon (22-29) |
Agonist |
98.12% |
Unkown |
| HY-141842 |
GLP-1R modulator L7-028 |
Modulator |
99.47% |
Unkown |
| HY-148212 |
GLP-1R agonist 17 |
Agonist |
99.82% |
Unkown |
| HY-P10031A |
SAR441255 TFA |
|
99.93% |
Unkown |
| HY-172811 |
DA-302168S |
Agonist |
98.01% |
Unkown |
| HY-116854 |
NNC 92-1687 |
Antagonist |
98.74% |
Unkown |
| HY-13443B |
Exendin-4-Lys-azide TFA |
Agonist |
99.84% |
Unkown |
| HY-145632A |
Pemvidutide TFA |
Antagonist |
98.07% |
Unkown |
| HY-P1145 |
Glucagon-like peptide 1 (1-37), human |
Agonist |
99.70% |
Unkown |
| HY-P5815A |
GLP-1 (1-36) amide (human, rat) TFA |
|
98.02% |
Unkown |
| HY-148844 |
GCGR antagonist 2 |
Antagonist |
98.17% |
Unkown |
| HY-P3622 |
(Ser8)-GLP-1 (7-36) amide, human |
Agonist |
99.10% |
Unkown |
| HY-141839 |
GLP-1R modulator C16 |
Modulator |
98.67% |
Unkown |
| HY-153476A |
GIP/GLP-1 dual receptor agonist-1 sodium |
Agonist |
98.33% |
Unkown |
| HY-P10032A |
NN1177 TFA |
Agonist |
99.22% |
Unkown |
| HY-P3491 |
Pegloxenatide |
Agonist |
90.00% |
Unkown |
| HY-P1543 |
Exendin-3 |
Antagonist |
99.89% |
Unkown |
| HY-P1228 |
HAEGTFT |
|
98.81% |
Unkown |
| HY-119739 |
Skyrin |
Antagonist |
97.0% |
Unkown |
| HY-108795B |
[Gly8]-GLP-1(7-37) acetate |
Agonist |
99.11% |
Unkown |
| HY-P4146B |
Survodutide sodium |
Agonist |
/ |
Unkown |
| HY-124803 |
GPCR modulator-1 |
Modulator |
/ |
Unkown |
| HY-P1224 |
HAEGTFTSDVS |
|
98.62% |
Unkown |
| HY-P1231 |
GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS |
|
99.03% |
Unkown |
| HY-116819A |
VU0453379 hydrochloride |
Modulator |
99.0% |
Unkown |
| HY-P2497 |
Exendin (5-39) |
Antagonist |
99.43% |
Unkown |
| HY-P1223 |
Exendin-3/4 (59-86) |
|
98.19% |
Unkown |
| HY-P1225 |
{Val1}-Exendin-3/4 |
|
99.45% |
Unkown |
| HY-P1227 |
SDV-Exendin-3/4 |
|
95.96% |
Unkown |
| HY-P1143 |
[Des-His1,Glu9]-Glucagon amide |
Antagonist |
99.32% |
Unkown |
| HY-P5074 |
GRPP (human) |
Agonist |
98.94% |
Unkown |
| HY-147622 |
GLP-1R agonist 9 |
Agonist |
/ |
Unkown |
| HY-P1226 |
HAEGTFTSD |
Agonist |
98.48% |
Unkown |
| HY-P10341 |
ZP3022 |
Agonist |
98.00% |
Unkown |
| HY-144035 |
GLP-1R agonist 4 |
Agonist |
98.26% |
Unkown |
| HY-P1229 |
FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS |
|
98.01% |
Unkown |
| HY-142162A |
(S,R)-LSN3318839 |
Control |
98.25% |
Unkown |
| HY-P11274 |
Zenagamtide |
Agonist |
/ |
Unkown |
| HY-128781 |
Glucagon receptor antagonist-5 |
Antagonist |
/ |
Unkown |
| HY-138996 |
GLP-1 receptor agonist 8 |
Agonist |
/ |
Unkown |
| HY-P4843 |
Gastric Inhibitory Polypeptide (6-30) amide (human) |
|
/ |
Unkown |
| HY-P0211 |
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) |
Antagonist |
/ |
Unkown |
| HY-128103 |
Glucagon receptor antagonist-7 |
Antagonist |
/ |
Unkown |
| HY-P5578A |
A8SGLP-1 TFA |
Agonist |
/ |
Unkown |
| HY-172673 |
GLP-1R agonist 31 |
Agonist |
/ |
Unkown |
| HY-P3542 |
Des His1, Glu8 Exendin-4 |
Antagonist |
/ |
Unkown |
| HY-P3616 |
Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide |
|
/ |
Unkown |
| HY-129657 |
GLP-1 receptor agonist 4 |
Agonist |
/ |
Unkown |
| HY-P11275 |
TC4 |
Agonist |
/ |
Unkown |
| HY-P11818 |
GIPR/GLP-1R/GCGR agonist-1 |
|
/ |
Unkown |
| HY-P3053 |
Helospectin I |
|
/ |
Unkown |
| HY-P4503 |
(D-His1)-Exenatide |
Control |
/ |
Unkown |
| HY-P4459 |
(Des-Gly2)-Exenatide |
Control |
/ |
Unkown |
| HY-P5578 |
A8SGLP-1 |
Agonist |
/ |
Unkown |
| HY-P11487 |
UTG-4 |
Agonist |
/ |
Unkown |
| HY-P1144A |
Oxyntomodulin (bovine, porcine) TFA |
Agonist |
/ |
Unkown |
| HY-P3608 |
[Des-His1,Glu9] Glucagon |
Antagonist |
/ |
Unkown |
| HY-P3539 |
Exendin-4 (3-39) |
|
/ |
Unkown |
| HY-13443F |
Exendin 4, biotin labeled |
Agonist |
/ |
Unkown |
| HY-129658 |
TT-OAD2 free base |
Agonist |
/ |
Unkown |
| HY-144135 |
GLP-1R agonist 7 |
Agonist |
/ |
Unkown |
| HY-P2880 |
PHI-27 (porcine) |
|
/ |
Unkown |
| HY-177156 |
Glucagon receptor antagonist-8 |
Antagonist |
/ |
Unkown |
| HY-P10337 |
OXM-7 |
Agonist |
/ |
Unkown |
| HY-P11044 |
GEP12 |
Agonist |
/ |
Unkown |
| HY-P3050 |
Helospectin II |
Inhibitor |
/ |
Unkown |
| HY-P11279 |
TC2 |
Agonist |
/ |
Unkown |
| HY-P3621 |
Biotinyl-Glucagon (1-29), human, bovine, porcine |
|
/ |
Unkown |
| HY-107129 |
MK-3577 |
Antagonist |
/ |
Unkown |
| HY-P5161 |
FC382K10W15 |
Agonist |
/ |
Unkown |
| HY-P1160A |
Bay 55-9837 TFA |
|
/ |
Unkown |
| HY-144133 |
GLP-1R agonist 5 |
Agonist |
/ |
Unkown |
| HY-120401 |
Glybuzole |
Activator |
/ |
Unkown |
| HY-P0212 |
Neuropeptide Y, porcine |
Agonist |
/ |
Unkown |
| HY-159696A |
ISIS 449884 sodium |
Inhibitor |
/ |
Unkown |
| HY-181709 |
TPM003 |
Agonist |
/ |
Unkown |
| HY-P0212A |
Neuropeptide Y, porcine TFA |
|
/ |
Unkown |
| HY-D3173 |
TP-α |
Modulator |
/ |
Unkown |
| HY-159696B |
ISIS 449884 sodium scrambled negative control |
Inhibitor |
/ |
Unkown |
| HY-153476 |
GIP/GLP-1 dual receptor agonist-1 |
Agonist |
/ |
Unkown |
| HY-171851 |
GLP-1R agonist 32 |
Agonist |
/ |
Unkown |
| HY-P11881 |
IUB288 |
Agonist |
/ |
Unkown |
| HY-13443S |
Exendin-4 (Leu-13C6,15N) TFA |
|
/ |
Unkown |
| HY-129656 |
GLP-1 receptor agonist 3 |
Agonist |
/ |
Unkown |
| HY-169707 |
GCGR antagonist 3 |
Antagonist |
/ |
Unkown |
| HY-P2625S1 |
GLP-2(3-33) (Leu-13C6,15N) TFA |
Agonist |
/ |
Unkown |
| HY-12525B |
LGD 6972 ammonium |
Antagonist |
/ |
Unkown |
| HY-144134 |
GLP-1R agonist 6 |
Agonist |
/ |
Unkown |
| HY-P4672 |
(Met(O)27)-Glucagon (1-29) (human, rat, porcine) |
|
/ |
Unkown |
| HY-159696 |
ISIS 449884 |
Inhibitor |
/ |
Unkown |
| HY-106559 |
Sorbinicate |
Inhibitor |
/ |
Unkown |
| HY-P3101A |
GLP-1(28-36)amide TFA |
|
/ |
Unkown |
| HY-P3102A |
GLP-1(32-36)amide TFA |
|
/ |
Unkown |
| HY-P11880 |
LY3324954 |
Agonist |
/ |
Unkown |
| HY-P5161A |
FC382K10W15 TFA |
Agonist |
/ |
Unkown |
| HY-172836S |
GLP-1 receptor agonist 17-d3 |
Agonist |
/ |
Unkown |
| HY-144136 |
GLP-1R agonist 8 |
Agonist |
/ |
Unkown |
| HY-144033 |
GLP-1R agonist 1 |
Agonist |
/ |
Unkown |
| HY-180445 |
Glucagon receptor antagonist-10 |
Antagonist |
/ |
Unkown |
| HY-12525A |
LGD-6972 sodium |
Antagonist |
/ |
Unkown |
| HY-125824A |
Danuglipron tromethamine |
Agonist |
/ |
Unkown |
| HY-12735 |
SCH 900822 |
Antagonist |
/ |
Unkown |
| HY-160281 |
CCD-2 |
|
/ |
Unkown |
| HY-180446 |
Glucagon receptor antagonist-11 |
Antagonist |
/ |
Unkown |
| HY-180444 |
Glucagon receptor antagonist-9 |
Antagonist |
/ |
Unkown |
| HY-118914 |
Glucagon receptor antagonist inactive control |
Control |
/ |
Unkown |